Eli Lilly
1,887 hedge funds and large institutions have $133B invested in Eli Lilly in 2020 Q4 according to their latest regulatory filings, with 243 funds opening new positions, 661 increasing their positions, 677 reducing their positions, and 103 closing their positions.
136% more first-time investments, than exits
New positions opened: 243 | Existing positions closed: 103
22% more capital invested
Capital invested by funds: $109B → $133B (+$24.1B)
6% more funds holding
Funds holding: 1,773 → 1,887 (+114)
5.37% more ownership
Funds ownership: 76.89% → 82.26% (+5.4%)
8% more call options, than puts
Call options by funds: $870M | Put options by funds: $807M
2% less repeat investments, than reductions
Existing positions increased: 661 | Existing positions reduced: 677
2% less funds holding in top 10
Funds holding in top 10: 49 → 48 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$7.46B |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$1.17B |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$610M |
| 4 |
JP Morgan Chase
New York
|
+$399M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$285M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
-$712M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$631M |
| 3 |
Jennison Associates
New York
|
-$403M |
| 4 |
Two Sigma Advisers
New York
|
-$283M |
| 5 |
BlackRock
New York
|
-$248M |
LLY Hedge Fund Activity: Q4 2020 in Review
1,887 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q4 2020, worth a combined $133B — up 22% from $109B a quarter earlier.
Buyers outnumbered sellers: 243 funds opened new LLY positions and 103 closed out — a net gain of 140 holders — while 661 added to existing stakes and 677 trimmed.
The largest buyer was PNC Financial Services Group, adding an estimated $7.46B. The largest seller was Capital International Investors, cutting an estimated $712M.
- 1,887 institutional investors held Eli Lilly (LLY) as of Q4 2020, up from 1,773 in Q3 2020.
- Funds reported $133B of Eli Lilly stock for Q4 2020, up 22% quarter-over-quarter.
- 243 funds opened new Eli Lilly positions in Q4 2020 and 103 closed out, a net change of +140 holders.
- The largest Eli Lilly buyer in Q4 2020 was PNC Financial Services Group, an estimated $7.46B added.
- The largest Eli Lilly seller in Q4 2020 was Capital International Investors, an estimated $712M sold.
Based on aggregated 13F filings for Q4 2020.